Empowering Scientific Discovery through Advanced DNA Synthesis and Synthetic Biology Solutions

Founded in 2013, Synbio Technologies has established itself as a leading synthetic biology company, providing comprehensive DNA synthesis and related services to researchers and industries worldwide. With a mission to deliver highly accurate and cost-effective solutions, Synbio Technologies supports a wide array of applications, including gene synthesis, protein expression, gene editing, and beyond.

Core Services and Capabilities:

  • DNA Synthesis: Offering 100% accurate custom DNA synthesis services, Synbio Technologies excels in constructing complex DNA sequences, including gene synthesis, pathway synthesis, and small genome synthesis.

  • Oligo Synthesis: Providing a wide range of oligonucleotide synthesis options, including custom DNA and RNA oligos with various modifications, suitable for applications such as PCR, qPCR, and next-generation sequencing (NGS). 

  • Gene Editing: Supporting precision gene editing projects with services like sgRNA customized design, CRISPR library construction, and high-throughput gene editing vectors, facilitating advancements in functional genomics research. 

  • Protein Expression: Delivering recombinant protein production services across multiple expression systems, including mammalian, bacterial, yeast, and insect cells, tailored to meet diverse research and therapeutic needs. 

  • Antibody Services: Offering comprehensive antibody-related services, such as hybridoma antibody sequencing, antibody humanization, affinity maturation, and recombinant antibody production, accelerating the development of therapeutic antibodies.

  • Peptide Services: Providing custom peptide synthesis, peptide libraries, and various peptide modifications to support research in immunology, drug discovery, and structural biology.

Headquartered in Monmouth Junction, New Jersey, with additional facilities in China, Synbio Technologies serves a global clientele, including academic institutions, biotechnology companies, and pharmaceutical firms. Their commitment to quality is underscored by adherence to rigorous standards and the integration of advanced technologies to ensure precision and reproducibility in every project.

By partnering with Synbio Technologies, researchers and organizations gain access to a versatile and reliable collaborator dedicated to advancing the frontiers of synthetic biology and enabling groundbreaking discoveries.

Synbio Technologies